Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/a-concise-guide-to-nuclear-medicine-nuclear-medicine-in-the-nervous-UH0snmM4G9
References (3)
-
D. Jennings, J. Seibyl, D. Oakes, S. Eberly, J. Murphy, K. Marek (2004)
(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.Archives of neurology, 61 8
-
G. Conrad, P. Sinha (2003)
Scintigraphy as a confirmatory test of brain death.Seminars in nuclear medicine, 33 4
-
K. Ishibashi, Yuko Saito, S. Murayama, K. Kanemaru, K. Oda, K. Ishiwata, H. Mizusawa, K. Ishii (2009)
Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 37
- Publisher
- Springer International Publishing
- Copyright
- © Springer Nature Switzerland AG 2020
- ISBN
- 978-3-030-26063-7
- Pages
- 125 –134
- DOI
- 10.1007/978-3-030-26064-4_9
- Publisher site
- See Chapter on Publisher Site
Abstract
[Cerebral blood flow and metabolism are generally interconnected. Alterations in brain function are associated with corresponding changes in perfusion. Radionuclide brain perfusion studies using lipophilic tracers are useful in the study of abnormalities of regional perfusion such as stroke and in the evaluation of changes related to neuronal activity like epilepsy and trauma. Their use in psychiatric conditions is promising. Several radiopharmaceuticals are used for imaging central nervous system. These include 99mTc-HMPAO (Fig. 9.1), PET tracers such as F-18 FDG (Fig. 9.2) and less commonly In-111 DTPA.]
Published: Aug 30, 2019